| Sears Hearing Aid Centers | |
|
5 Westbank Expy, Gretna, LA 70053-3637 | |
| (504) 708-4440 | |
| Not Available |
| Full Name | Sears Hearing Aid Centers |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 5 Westbank Expy, Gretna, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992012884 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Sears Hearing Aid Centers 10570 Se Washington St, Suite 210, Portland, OR 97216-2846 Ph: (503) 257-6800 | Sears Hearing Aid Centers 5 Westbank Expy, Gretna, LA 70053-3637 Ph: (504) 708-4440 |
News Archive
Following a successful Phase 1 study for safety, researchers at MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 2 clinical trial testing the ability of a human monoclonal antibody they developed to prevent hepatitis C virus infection of a donor liver in transplant patients.
In a Theory and Hypothesis paper titled "Somatic Experiencing: Using Interoception and Proprioception as Core Elements of Trauma Therapy," published today in Frontiers in Psychology, Dartmouth investigators Peter Payne, SEP, and Mardi Crane-Godreau, PhD, note the lack of hypothesized scientific models for the mechanisms of action responsible for outcomes in Somatic Experiencing® (SE) trauma therapy and other body-mind therapies.
The cost of treating men for heart disease topped $47 billion in 2008, leading a list of the 10 most expensive conditions for men age 18 and older, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The leopard cannot change its spots, nor can the tiger change its stripes, but a new research report published in the January 2009 issue of the journal GENETICS tells us something about how cats end up with their spots and stripes
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
› Verified 1 days ago
Mrs. Lindsay W Johnson, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 44 Colony Rd, Gretna, LA 70056 Phone: 504-909-8063 | |
Taylor Farrar, AU.D., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 120 Ochsner Blvd, Gretna, LA 70056 Phone: 504-371-9355 | |
Ansley Nelson, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2550 Belle Chasse Hwy Ste 225, Gretna, LA 70053 Phone: 800-328-8602 | |
Ashleigh M Dewell, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 120 Ochsner Blvd Ste 200, Gretna, LA 70056 Phone: 504-391-7650 Fax: 504-394-7344 | |
Teri C Bairnsfather, MS.,FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 120 Meadowcrest St, Suite 200, Gretna, LA 70056 Phone: 504-391-7650 Fax: 504-394-7344 | |
Sarah E Baur, MA,CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 120 Meadowcrest St Ste 200, Gretna, LA 70056 Phone: 504-391-7650 |